Positive update on Asterias’ SCiStar study for spinal cord injury – TMM 2017

Author: Samantha Yammine, 11/23/17

With the extensive exploitation of regenerative medicine through the marketing and selling of unapproved stem cell “therapies” online, it was refreshing to hear an update about clinical trials for a legitimate stem cell therapy at the Till & McCulloch Meetings (TMM) earlier this month. Dr. Jane Lebkowski, President of R&D and Chief Scientific Officer at…Read more

Right Turn: What’s “scienceploitation” and how can you stop it?

Author: Stacey Johnson, 11/17/17

  Timothy Caulfield is a crusader against pseudoscience and “scienceploitation” as he likes to call the field of exploiting science for marketing purposes. He was one of the speakers in a lunch time panel, at the recent Till & McCulloch Meetings, on ethical, legal and social issues. The title of the panel was “Science for…Read more

A second chance at life after a diagnosis of Multiple Sclerosis – Day 2 at TMM 2017

Author: Hamideh Emrani, 11/16/17

Imagine your hands lose their control and, all of a sudden, the glass of water you just took from the fridge slips and shatters on the ground. What could it be? “It is probably carpel tunnel syndrome,” says your family doctor. But you experience more problematic symptoms like double vision and loss of balance and,…Read more

Taming the unruly immune system: the risky stem cell transplant that changed the fate of some Canadian MS patients – Day 2 at TMM 2017

Author: Hamideh Emrani, 11/16/17

  This year, Dr. Harold Atkins was honored with the Till & McCulloch Award. He and Dr. Mark Freedman led a clinical trial that used stem cells to reset the immune system as a treatment strategy for Multiple Sclerosis (MS) and a few other neurodegenerative diseases, such as stiff person syndrome. You can read how…Read more

Right Turn: Dateline Mont-Tremblant – TMM 2017

Author: Stacey Johnson, 11/10/17

November 5-8, 2017, Mont-Tremblant, Quebec. The ski resort town of Mont-Tremblant was awash in rain when many of us arrived on Sunday, but the warm and welcoming Fairmont Hotel made up for Nature’s inhospitality. By all measures, the parts we could control were very successful. The 6th annual Till & McCulloch Meetings (TMM), hosted by…Read more

Ingenious methods to engineer cells to treat diabetes – Day 1 TMM 2017

Author: Hamideh Emrani, 11/09/17

  Another interesting talk, on the first morning of the Canadian Till & McCulloch Meetings, was from Dr. Bruce Verchere who spoke about possible routes to prevent graft rejection in the case of human β-cell and islet cell transplants for diabetes through engineering the β-cells. As previously described, Type 1 diabetes (T1D) is an autoimmune…Read more

Novel technique used to study organ development – Day 1 of TMM 2017

Author: Hamideh Emrani, 11/08/17

This year’s Till & McCulloch Meetings began with a rainy day on the beautiful mountainside in Mont-Tremblant, Quebec. The morning talks started off with Dr. Matthias Lütolf. His lab at the École Polytechnique Fédérale de Lausanne, (EPFL) works on strategies to improve culture and growth of stem cells in lab settings. One of these strategies…Read more

Seeing isn’t always believing: a cautionary tale when trying to restore vision – TMM 2017

Author: Guest, 11/07/17

Samantha is a PhD Candidate studying neural stem cell biology in Dr. Derek van der Kooy’s lab at the University of Toronto. Her research focuses on neural stem cell hierarchies in the developing mammalian brain, and activation of quiescent stem cells in the adult brain. She is also an avid science communicator on social media…Read more

Right Turn: Considering a career in science or engineering?

Author: Stacey Johnson, 11/03/17

Did you notice surprisingly young-looking employees at your workplace this week? If you’re suffering from that getting old syndrome where that kid at the cash looks 12, but is actually a 27-year-old mother of two, then you may be relieved to know that your eyes weren’t playing tricks on you. Those were 14-year-olds in the…Read more

Engineered stem cell platform gives new insights into beginnings of human development

Author: Guest, 11/01/17

Ann Perry is senior communications officer at Medicine by Design at the University of Toronto. She previously held strategic communications roles in the Ontario government and not-for-profit sector, and was an editorial writer, reporter and editor at the Toronto Star. You can follow Medicine by Design on Twitter @MbD_UofT. This article first appeared on Medicine…Read more